Suchergebnisse

1660 Treffer:
The sentinel lymph node concept in prostate cancer - first results of gamma probe-guided sentinel lymph node identification.
Wawroschek F, Vogt H, Weckermann D, Wagner T, Harzmann R.
Reicht die modifizierte pelvine Staging - Lymphadenektomie beim Prostatakarzinom zur Erfassung von Mikrometastasen aus?
Wawroschek F, Vogt H, Weckermann D, Wagner Th, Harzmann R.
Micrometastases of bone marrow in localized prostate cancer: correlation with established risk factors.
Weckermann D, Müller P, Wawroschek F, Krawczak G, Riethmüller G, Schlimok G.
Metabolic changes and urodynamic findings after continent urinary diversion.
Weckermann D, Wawroschek F, Schipp J, Krawczak G, Harzmann.
Improved discrimination of prostate cancer and benign prostatic hyperplasia by means of the quotient of free and total PSA.
Weckermann D, Maassen C, Wawroschek F, Harzmann R.
Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy?
Weckermann D, Wawroschek F, Krawczak G, Haude KH, Harzmann R.
First sentinel based nomogram predicting the probability of lymph node involvement in prostate cancer patients undergoing radio guided lymph node dissection and radical retropubic prostatectomy.
Winter A, Kneib Th, Schatke N, Rohde M, Henke RP, Wawroschek F.
Interne Validierung des ersten auf der Sentinel-Lymphadenektomie basierenden Nomogramms zur Vorhersage von Lymphknotenmetastasen beim Prostatakarzinom.
Winter A, Kneib Th, Schatke N, Rohde M, Henke RP, Wawroschek F.
Complications of Pelvic Lymphadenectomy in Clinically Localised Prostate Cancer: Different Techniques in Comparison and Dependency on the Number of Removed Lymph Nodes.
Winter A, Vogt C, Weckermann D, Wawroschek F.
Methods and current significance of the evaluation of microscopic haematuria.
Hüppe P, Wawroschek F.
Suchergebnisse 981 bis 990 von 1660